Method-Of-Treatment Patent Eligibility: Step 1 And Done?

By Thomas Hedemann and David Ludwig (February 5, 2019, 1:39 PM EST) -- Seven years ago, the U.S. Supreme Court in Mayo Collaborative Services v. Prometheus Laboratories Inc.[1] introduced a two-step test for determining whether life sciences patents are invalid as claiming patent ineligible subject matter under 35 U.S.C § 101.[2] step one asks whether the claims are "directed to" a patent ineligible concept, i.e., a natural law, natural phenomenon or abstract idea. If not, the claims are patentable subject matter and the inquiry ends. If they are directed to a patent ineligible concept, step two asks whether the claims contain "significantly more" to "transform that [patent ineligible concept] into a patent-eligible invention."[3] Following...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!